---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-21-019541"
form_type: "8-K"
ticker: "RNGE"
cik: "0001438943"
company_name: "RANGE IMPACT, INC."
filed_at: "2021-08-12T23:59:59+00:00"
generated_at: "2026-06-29T12:45:51.333518+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Vitality Biopharma shareholders elect directors and approve 2021 Stock Incentive Plan at annual meeting.

## Summary
- Edward Feighan, Richard Celeste, Michael Cavanaugh elected as directors with >98% votes for.
- 2021 Stock Incentive Plan approved: 21,209,644 votes for, 638,306 against.
- Advisory vote on executive compensation approved: 21,298,713 for, 523,948 against.
- Stockholders preferred advisory votes on exec comp every 3 years (21,021,589 votes); board adopted that frequency.
- Ratification of Meaden & Moore as auditor: 27,454,815 for, 101,379 against.

## SEC filing metadata
- accession: 0001493152-21-019541
- form_type: 8-K
- ticker: RNGE
- cik: 0001438943
- company_name: RANGE IMPACT, INC.
- filed_at: 2021-08-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438943/000149315221019541/0001493152-21-019541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438943/000149315221019541/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-21-019541
- JSON: https://secwatch.observer/filing/0001493152-21-019541.json
- Plain text: https://secwatch.observer/filing/0001493152-21-019541.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.